slotkoers
Korea S.E.
00:00:00 28-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
11.930
KRW
|
+0,42%
|
|
0,00%
|
-7,30%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
347.568
|
313.524
|
328.567
|
214.461
|
188.137
|
199.286
|
Bedrijfswaarde
1 |
389.821
|
348.370
|
362.512
|
255.871
|
226.460
|
217.251
|
K/w-verhouding
|
22
x
|
14,3
x
|
19
x
|
16,7
x
|
12,6
x
|
7,08
x
|
Dividendrendement
|
2,28%
|
2,53%
|
2,41%
|
3,61%
|
4,12%
|
3,89%
|
Marktkapitalisatie/omzet
|
2,24
x
|
1,84
x
|
1,79
x
|
1,26
x
|
1
x
|
0,96
x
|
Bedrijfswaarde/omzet
|
2,51
x
|
2,05
x
|
1,98
x
|
1,51
x
|
1,2
x
|
1,05
x
|
Bedrijfswaarde/EBITDA
|
11,3
x
|
8,42
x
|
7,01
x
|
6,14
x
|
5,39
x
|
4,68
x
|
Bedrijfswaarde/FCF
|
17,3
x
|
23,2
x
|
16,6
x
|
24,9
x
|
26
x
|
8,11
x
|
FCF Yield
|
5,79%
|
4,32%
|
6,01%
|
4,01%
|
3,85%
|
12,3%
|
Price to Book
|
3,18
x
|
2,56
x
|
2,48
x
|
1,63
x
|
1,34
x
|
1,25
x
|
Aantal aandelen (in duizenden)
|
15.835
|
15.835
|
15.835
|
15.485
|
15.485
|
15.485
|
Referentieprijs
2 |
21.950
|
19.800
|
20.750
|
13.850
|
12.150
|
12.870
|
Datum van publicatie
|
21-03-19
|
19-03-20
|
25-03-21
|
28-03-22
|
21-03-23
|
14-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
155.230
|
170.221
|
183.521
|
169.817
|
188.931
|
206.860
|
EBITDA
1 |
34.640
|
41.375
|
51.697
|
41.661
|
42.045
|
46.393
|
Bedrijfsresultaat (EBIT)
1 |
23.541
|
29.749
|
39.451
|
28.417
|
27.089
|
30.862
|
Operationele Marge
|
15,17%
|
17,48%
|
21,5%
|
16,73%
|
14,34%
|
14,92%
|
Resultaat voor belastingen (EBT)
1 |
21.311
|
28.331
|
22.740
|
18.287
|
20.782
|
33.708
|
Nettowinst (verlies)
1 |
15.821
|
21.938
|
17.300
|
12.914
|
14.961
|
28.144
|
Nettomarge
|
10,19%
|
12,89%
|
9,43%
|
7,6%
|
7,92%
|
13,61%
|
WPA
2 |
999,1
|
1.385
|
1.093
|
828,8
|
966,0
|
1.818
|
Free Cash Flow
1 |
22.573
|
15.043
|
21.798
|
10.273
|
8.717
|
26.784
|
FCF-marge
|
14,54%
|
8,84%
|
11,88%
|
6,05%
|
4,61%
|
12,95%
|
Kasstroomconversie (ebitda)
|
65,17%
|
36,36%
|
42,16%
|
24,66%
|
20,73%
|
57,73%
|
Kasstroomconversie (nettowinst)
|
142,68%
|
68,57%
|
126%
|
79,55%
|
58,26%
|
95,17%
|
Dividend per aandeel
2 |
500,0
|
500,0
|
500,0
|
500,0
|
500,0
|
500,0
|
Datum van publicatie
|
21-03-19
|
19-03-20
|
25-03-21
|
28-03-22
|
21-03-23
|
14-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
42.253
|
34.846
|
33.945
|
41.410
|
38.322
|
17.965
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
1,22
x
|
0,8422
x
|
0,6566
x
|
0,994
x
|
0,9115
x
|
0,3872
x
|
Free Cash Flow
1 |
22.573
|
15.043
|
21.798
|
10.273
|
8.717
|
26.784
|
ROE (netto-inkomsten/eigen vermogen)
|
15%
|
18,9%
|
13,6%
|
9,78%
|
11%
|
18,8%
|
ROA (netto-inkomsten/totale activa)
|
7,37%
|
9,24%
|
11,9%
|
8,19%
|
7,17%
|
7,58%
|
Totale activa
1 |
214.731
|
237.321
|
145.874
|
157.733
|
208.729
|
371.180
|
Nettoactief per aandeel
2 |
6.900
|
7.744
|
8.367
|
8.492
|
9.063
|
10.294
|
Cashflow per aandeel
2 |
807,0
|
623,0
|
164,0
|
318,0
|
253,0
|
1.306
|
Capex
1 |
10.042
|
8.092
|
15.931
|
18.976
|
8.079
|
8.153
|
Capex/omzet
|
6,47%
|
4,75%
|
8,68%
|
11,17%
|
4,28%
|
3,94%
|
Datum van publicatie
|
21-03-19
|
19-03-20
|
25-03-21
|
28-03-22
|
21-03-23
|
14-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -7,30% | 134 mln. | | +55,32% | 815 mld. | | +44,05% | 641 mld. | | -6,75% | 352 mld. | | +13,56% | 314 mld. | | +10,68% | 303 mld. | | +16,57% | 242 mld. | | +13,31% | 218 mld. | | +8,48% | 168 mld. | | -2,81% | 159 mld. |
Farmaceutische producten - Andere
|